Fresenius Medical Care AG & Co. KGaA (ETR:FME) has been assigned a €92.10 ($108.35) price target by equities researchers at Berenberg Bank in a note issued to investors on Tuesday, August 1st. The firm presently has a “buy” rating on the stock.

A number of other equities analysts have also recently weighed in on FME. Deutsche Bank AG set a €87.00 ($102.35) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research report on Tuesday, April 25th. HSBC Holdings plc set a €83.00 ($97.65) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “neutral” rating in a research report on Wednesday, April 26th. Citigroup Inc. set a €92.00 ($108.24) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Thursday, April 27th. Morgan Stanley set a €90.00 ($105.88) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research report on Thursday, April 27th. Finally, Goldman Sachs Group, Inc. (The) set a €100.00 ($117.65) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a report on Wednesday, May 3rd. One analyst has rated the stock with a sell rating, nine have given a hold rating and ten have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of €88.21 ($103.78).

Shares of Fresenius Medical Care AG & Co. KGaA (FME) traded up 1.143% during trading on Tuesday, hitting €77.425. The stock had a trading volume of 2,002 shares. The stock has a 50-day moving average price of €82.48 and a 200 day moving average price of €81.13. Fresenius Medical Care AG & Co. KGaA has a 12 month low of €70.82 and a 12 month high of €89.07. The company has a market cap of €23.76 billion and a P/E ratio of 19.965.

TRADEMARK VIOLATION NOTICE: “Fresenius Medical Care AG & Co. KGaA (FME) PT Set at €92.10 by Berenberg Bank” was posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at https://theolympiareport.com/2017/08/12/berenberg-bank-analysts-give-fresenius-medical-care-ag-92-10-price-target-updated.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with Analyst Ratings Network's FREE daily email newsletter.